216 patents currently held
48 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Nov 2026. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
34
Ending by 2030
Nov 2026
Next term end
143
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jan 2028 · High confidence
Also notable
Ends no later than Nov 2027 · Medium confidence
Also notable
Ends Nov 2029 · High confidence
Also notable
Ends May 2034 · High confidence
Also notable
Ends Mar 2030 · High confidence
Also notable
Ends Oct 2033 · High confidence
Also notable
Ends Mar 2032 · High confidence
Also notable
Ends Mar 2033 · High confidence
Endoscopic Methods and Devices for Transnasal Procedures
US 9,265,407
Cited by 333 later US patents, top 1% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2028.
Balloon Catheters and Methods for Treating Paranasal Sinuses
US 8,317,816
Cited by 327 later US patents, top 1% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Eustachian Tube Dilation Balloon with Ventilation Path
US 10,206,821
Cited by 33 later US patents, top 10% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2029.
Balloon Dilation Catheter System for Treatment and Irrigation of the Sinuses
US 9,579,448
Cited by 79 later US patents, top 5% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2034.
Guide System with Suction
US 10,524,814
Cited by 43 later US patents, top 5% of utility patents granted in 2020 in our data. Protection runs to 2030.
Paranasal Ostium Finder Devices and Methods
US 8,979,888
Cited by 119 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2033.
Methods and Apparatus for Treating Disorders of the Sinuses
US 11,534,192
Cited by 33 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2032.
Devices and Method for Maxillary Sinus Lavage
US 10,166,369
Cited by 12 later US patents, top 25% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2033.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Nov 23 to 28, 2026 · next Nov 23
- 2 fees due Dec 20 to 27, 2026 · next Dec 20
- 4 fees due Jan 11 to 30, 2027 · next Jan 11
- 3 fees due Feb 1 to 20, 2027 · next Feb 1
- 1 fee due Mar 5, 2027The maintenance fee for Devices and Method for Maxillary Sinus Lavage (US 11,744,994) comes due Mar 5, 2027. Unpaid by Sep 7, 2027, it lapses early.
- 4 fees due Apr 13 to 30, 2027 · next Apr 13
- 4 fees due May 5 to 28, 2027 · next May 5
- 8 fees due Jun 5 to 26, 2027 · next Jun 5
- 3 fees due Jul 7 to 30, 2027 · next Jul 7
- 4 fees due Aug 4 to 25, 2027 · next Aug 4
- 2 fees due Sep 12 to 30, 2027 · next Sep 12
- 6 fees due Oct 2 to 23, 2027 · next Oct 2
- 1 fee due Nov 5, 2027The maintenance fee for Dilation System (US 10,639,462) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.
Recent changes
- 6 of the patents on this record were granted since Aug 23, 2026
- 8 terms have ended since Aug 23, 2026
- Oct 26 US 10,124,154 Catheters with Non-Removable Guide Members Useable for Treatment of Sinusitis · term ended
- Oct 5 US 9,468,362 Endoscopic Methods and Devices for Transnasal Procedures · term ended
- Sep 30 US 8,849,394 System and Method for the Simultaneous Bilateral Integrated Tympanic Drug Delivery and Guided Treatment of Target Tissues Within the Ears · lapsed on the fee record
- Sep 25 US 8,870,893 Devices, Systems and Methods for Diagnosing and Treating Sinusitis and Other Disorders of the Ears, Nose And/Or Throat · term ended
- Sep 23 US 8,840,602 Systems and Methods for Anesthetizing Ear Tissue · lapsed on the fee record
- Sep 15 US 9,572,480 Methods and Devices for Facilitating Visualization In a Surgical Environment · term ended
- Sep 15 US 10,716,629 Methods and Devices for Facilitating Visualization in a Surgical Environment · term ended
- Sep 8 US 11,202,644 Shapeable Guide Catheters and Related Methods · term ended
What they patent
The largest of its 143 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,399,121 | Systems and Methods for Transnasal Dilation of Passageways in the Ear, Nose or Throat In force · High confidence | In force | High confidence | |
| US 7,559,925 | Methods and Devices for Facilitating Visualization in a Surgical Environment In force · High confidence | In force | High confidence | |
| US 9,089,258 | Endoscopic Methods and Devices for Transnasal Procedures In force · High confidence | In force | High confidence | |
| US 10,874,838 | Systems and Methods for Transnasal Dilation of Passageways in the Ear, Nose or Throat In force · High confidence | In force | High confidence | |
| US 8,317,816 | Balloon Catheters and Methods for Treating Paranasal Sinuses In force · Medium confidence | In force | Medium confidence | |
| US 9,265,407 | Endoscopic Methods and Devices for Transnasal Procedures In force · High confidence | In force | High confidence | |
| US 9,463,068 | Methods and Devices for Protecting Nasal Turbinates In force · High confidence | In force | High confidence | |
| US 7,720,521 | Methods and Devices for Performing Procedures Within the Ear, Nose, Throat and Paranasal Sinuses In force · High confidence | In force | High confidence | |
| US 9,861,793 | Corewire Design and Construction for Medical Devices In force · High confidence | In force | High confidence | |
| US 7,803,150 | Devices, Systems and Methods Useable for Treating Sinusitis In force · High confidence | In force | High confidence |
Also on record, not counted in the 216: 48 patents in force now held by others · 114 patents ended · 39 applications pending · 122 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.